180 related articles for article (PubMed ID: 15654833)
1. Elevated macrophage migration inhibitory factor (MIF) levels in the urine of patients with focal glomerular sclerosis.
Matsumoto K; Maruyama N; Maruyama T; Ohnishi Y; Nonaka S; Inoshita A; Ito K; Kitajima S; Abe M; Satomura A; Fujita T
Clin Exp Immunol; 2005 Feb; 139(2):338-47. PubMed ID: 15654833
[TBL] [Abstract][Full Text] [Related]
2. Urinary levels of macrophage migration inhibitory factor in patients with IgA nephropathy.
Matsumoto K; Kanmatsuse K
Nephron; 2002 Oct; 92(2):309-15. PubMed ID: 12218308
[TBL] [Abstract][Full Text] [Related]
3. Urine macrophage migration inhibitory factor reflects the severity of renal injury in human glomerulonephritis.
Brown FG; Nikolic-Paterson DJ; Hill PA; Isbel NM; Dowling J; Metz CM; Atkins RC
J Am Soc Nephrol; 2002 Jan; 13 Suppl 1():S7-13. PubMed ID: 11792756
[TBL] [Abstract][Full Text] [Related]
4. Macrophage migration inhibitory factor is increased in the urine of patients with urinary tract infection: macrophage migration inhibitory factor-protein complexes in human urine.
Meyer-Siegler KL; Iczkowski KA; Vera PL
J Urol; 2006 Apr; 175(4):1523-8. PubMed ID: 16516040
[TBL] [Abstract][Full Text] [Related]
5. Determinants of focal and segmental glomerulosclerosis in the rat after renal ablation. Evidence for involvement of macrophages and lipids.
van Goor H; Fidler V; Weening JJ; Grond J
Lab Invest; 1991 Jun; 64(6):754-65. PubMed ID: 2046327
[TBL] [Abstract][Full Text] [Related]
6. [Analysis of intraglomerular and interstitial infiltration of leukocytes in membranous nephropathy with focal segmental glomerulosclerosis].
Yusa A; Saito T; Soma J; Ootaka T; Sato H; Abe K
Nihon Jinzo Gakkai Shi; 1996 Jun; 38(6):239-47. PubMed ID: 8752965
[TBL] [Abstract][Full Text] [Related]
7. Trauma patients with positive cultures have higher levels of circulating macrophage migration inhibitory factor (MIF).
Joshi PC; Poole GV; Sachdev V; Zhou X; Jones Q
Res Commun Mol Pathol Pharmacol; 2000; 107(1-2):13-20. PubMed ID: 11334363
[TBL] [Abstract][Full Text] [Related]
8. Studies of glomerular permeability factor (GPF) in focal segmental glomerular sclerosis and the relationship between GPF and vascular permeability factor (VPF).
Kondo S; Yoshizawa N; Kusumi Y; Takeuchi A; Torikata C
Clin Nephrol; 1999 Nov; 52(5):278-84. PubMed ID: 10584990
[TBL] [Abstract][Full Text] [Related]
9. Elevated vascular endothelial growth factor levels in the urine of patients with minimal-change nephrotic syndrome.
Matsumoto K; Kanmatsuse K
Clin Nephrol; 2001 Apr; 55(4):269-74. PubMed ID: 11334311
[TBL] [Abstract][Full Text] [Related]
10. [Study of correlation between urinary IL-6 level and mesangial lesion in childhood onset IgA nephropathy].
Akutsu Y
Hokkaido Igaku Zasshi; 1994 Jul; 69(4):686-96. PubMed ID: 7959587
[TBL] [Abstract][Full Text] [Related]
11. Aqueous levels of macrophage migration inhibitory factor and monocyte chemotactic protein-1 in patients with diabetic retinopathy.
Tashimo A; Mitamura Y; Nagai S; Nakamura Y; Ohtsuka K; Mizue Y; Nishihira J
Diabet Med; 2004 Dec; 21(12):1292-7. PubMed ID: 15569131
[TBL] [Abstract][Full Text] [Related]
12. Marked elevation of serum macrophage migration inhibitory factor levels in patients with pemphigus vulgaris.
Namazi MR; Fallahzadeh MK; Shaghelani H; Kamali-Sarvestani E
Int J Dermatol; 2010 Feb; 49(2):146-8. PubMed ID: 19799642
[TBL] [Abstract][Full Text] [Related]
13. Increased serum levels of macrophage migration inhibitory factor in patients with primary Sjögren's syndrome.
Willeke P; Gaubitz M; Schotte H; Maaser C; Domschke W; Schlüter B; Becker H
Arthritis Res Ther; 2007; 9(2):R43. PubMed ID: 17470266
[TBL] [Abstract][Full Text] [Related]
14. Increased serum levels of macrophage migration inhibitory factor in patients with Kawasaki disease.
Lee TJ; Chun JK; Yeon SI; Shin JS; Kim DS
Scand J Rheumatol; 2007; 36(3):222-5. PubMed ID: 17657678
[TBL] [Abstract][Full Text] [Related]
15. Analysis of macrophage migration inhibitory factor (MIF) in patients with idiopathic pulmonary fibrosis.
Bargagli E; Olivieri C; Nikiforakis N; Cintorino M; Magi B; Perari MG; Vagaggini C; Spina D; Prasse A; Rottoli P
Respir Physiol Neurobiol; 2009 Jul; 167(3):261-7. PubMed ID: 19464392
[TBL] [Abstract][Full Text] [Related]
16. Macrophage migration inhibitory factor expression in ovarian cancer.
Agarwal R; Whang DH; Alvero AB; Visintin I; Lai Y; Segal EA; Schwartz P; Ward D; Rutherford T; Mor G
Am J Obstet Gynecol; 2007 Apr; 196(4):348.e1-5. PubMed ID: 17403417
[TBL] [Abstract][Full Text] [Related]
17. Prominent increase of macrophage migration inhibitory factor in the sera of patients with uveitis.
Kitaichi N; Kotake S; Sasamoto Y; Namba K; Matsuda A; Ogasawara K; Onoé K; Matsuda H; Nishihira J
Invest Ophthalmol Vis Sci; 1999 Jan; 40(1):247-50. PubMed ID: 9888451
[TBL] [Abstract][Full Text] [Related]
18. The effect of Helicobacter pylori infection on expression of macrophage migration inhibitory factor by T cells and macrophages in gastric mucosa.
He XX; Yang J; Zheng XL; Ding YW; Shen QY; Liu W; Zhao YH
Chin Med J (Engl); 2005 Jul; 118(14):1201-5. PubMed ID: 16117866
[TBL] [Abstract][Full Text] [Related]
19. High mobility group box 1 (HMGB1) and macrophage migration inhibitory factor (MIF) in Kawasaki disease.
Hoshina T; Kusuhara K; Ikeda K; Mizuno Y; Saito M; Hara T
Scand J Rheumatol; 2008; 37(6):445-9. PubMed ID: 18720262
[TBL] [Abstract][Full Text] [Related]
20. Morphometric analysis of the glomerular capillary area--a comparison of minimal change nephrotic syndrome, focal glomerular sclerosis, and pre-eclampsia.
Ishitobi F; Sagiya A; Ueda Y; Oka K; Kanaya H; Iidaka K
J Pathol; 1991 Dec; 165(4):329-36. PubMed ID: 1783951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
